53Biologics, a leading CDMO specializing in biologics production and cGMP manufacturing for biological products, is pleased to announce the opening of a new GMP production line for microbial. The new production line boasts a 2000L reactor, making it one of the largest of its kind in the world.

This new addition to 53Biologics’s manufacturing facility allow them to meet the growing demand for microbial-based products and serve more clients across the globe. In addition to the 2000L reactor, the new GMP production line is equipped with a range of single-use downstream equipment, including chromatography systems, filtration units, and purification systems. These advanced technologies allow us to produce high-quality, pure biologics products with a high yield and efficiency.

“We are thrilled to add this new GMP manufacturing line to our existing capabilities for biologics production,” said Pablo Gutierrez, CEO of 53Biologics. “This investment not only expands our capacity to 2000L but also enhances our ability to deliver high-quality services to our clients. The larger volume of the fermenter enables us to scale-up production for larger batches, which can result in cost savings for our clients. It also enables us to better meet the growing demand for microbial-based biotherapeutics, which is increasingly becoming the focus of the pharmaceutical industry.”

The installation marks another milestone in 53Biologics’s ongoing efforts to expand its service offerings and meet the evolving needs of the biologics industry. With this new addition, 53Biologics is well-positioned to serve a wide range of clients, including those in the pharmaceutical, biotech and academic sectors.

“We are excited about the new opportunities this 2000L fermenter brings to our company and our clients,” said Francisco Reyes, Business Development Manager of 53Biologics. “We remain committed to delivering superior quality services to our clients, and this new fermenter will help us achieve that goal.”

About 53Biologics:

53Biologics is a CDMO with extensive experience in biologics production. The company offers a range of services for the biopharma industry, including process development, clinical manufacturing and analytical testing to support every step up to commercialization of biotherapeutics.

For more information contact Patricia De La Madrid, Marketing & Business Development Manager at 53Biologics through this email: pdelamadrid@53biologics.com